China
China
Shanghai, Shanghai Municipality, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma | CAR-T Cell Therapy; High-risk Large B-cell Lymphoma (LBCL) | Not yet recruiting | Not applicable | 2025-04-22 | NCT06935136 |